- VeteransCould accelerate development and dissemination of PTSD treatments by pooling U.S. and Israeli research expertise and cl…
- WorkersMay strengthen scientific collaboration and diplomatic ties between the United States and Israel and leverage existing…
- Potential benefitIs likely to create or sustain research and administrative jobs at participating U.S. universities and nonprofits (rese…
United States-Israel PTSD Collaborative Research Act
Referred to the House Committee on Armed Services.
This bill directs the Secretary of Defense, working with the Secretary of Veterans Affairs and the Secretary of State, to establish a time-limited grant program (to terminate seven years after the first award) under the Psychological Health and Traumatic Brain Injury Research Program to fund collaborative PTSD research between U.S. academic or nonprofit entities and Israeli institutions. Grants must fund joint U.S.–Israel research projects that address PTSD research priorities identified by the Secretary and comply with the 1972 United States‑Israel Binational Science Foundation agreement.
Progressive is most likely to raise humanitarian or rights-based concerns about partnering specifically with Israeli institutions given contemporary geopolitical context; conservatives emphasize strategic alliance benefits.
Relative to its intended legislative type, this bill successfully establishes a statutory basis for a U.S.–Israel PTSD collaborative research grant program and specifies responsible actors, applicant eligibility, a connection to an existing binational agreement, project reporting, and a 7‑year sunset.
This bill directs the Secretary of Defense, working with the Secretary of Veterans Affairs and the Secretary of State, to establish a time-limited grant program (to terminate seven years after the first award) under the Psychological Health and Traumatic Brain Injury Research Program to fund collaborative PTSD research between U.S. academic or nonprofit entities and Israeli institutions.
Grants must fund joint U.S.–Israel research projects that address PTSD research priorities identified by the Secretary and comply with the 1972 United States‑Israel Binational Science Foundation agreement.
The Secretary may accept conditioned gifts to support the program, must require applications and other criteria as established, and must report to Congress within 180 days of a project’s completion describing grant use and evaluating success.
On content alone, the bill is a narrowly targeted, administratively straightforward authorization addressing veterans' mental health and international research collaboration — topics that generally enjoy bipartisan sympathy. Key barriers are procedural (Senate floor time and possible holds), the absence of a specific appropriation in the bill, and any policy concerns about foreign partnerships or agency jurisdiction. The presence of a sunset, reporting requirements, and private gift authority mitigate some objections and improve manageability.
Relative to its intended legislative type, this bill successfully establishes a statutory basis for a U.S.–Israel PTSD collaborative research grant program and specifies responsible actors, applicant eligibility, a connection to an existing binational agreement, project reporting, and a 7‑year sunset. These elements align with the bill's substantive aim of creating grant authority.
Progressive is most likely to raise humanitarian or rights-based concerns about partnering specifically with Israeli institutions given contemporary geopolitical context; conservatives emphasize strategic alliance benefits.
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenCould raise data privacy, patient consent, and export-control concerns from sharing identifiable or sensitive medical d…
- Federal agenciesAdds another federally run grant program in an area already funded by DoD, VA, and NIH, which critics may view as dupli…
- StatesRequires administrative implementation by DoD (with VA and State coordination), generating regulatory and reporting bur…
Why the argument around this bill splits.
Progressive is most likely to raise humanitarian or rights-based concerns about partnering specifically with Israeli institutions given contemporary geopolitical context; conservatives emphasize strategic alliance benef…
A mainstream liberal would generally welcome more research into PTSD and stronger coordination between the Departments of Defense and Veterans Affairs on treatments for veterans and civilians who experience trauma.
They may cautiously support international scientific collaboration when it promises improved clinical outcomes, but could raise concerns about the specific U.S.–Israel partnership if recent Israeli government or military actions raise human-rights or humanitarian concerns.
They will also want to ensure research includes women, minority veterans, survivors of military sexual trauma, and that findings are accessible and used to expand treatment access domestically.
A pragmatic centrist would view the bill positively as a focused, time-limited effort to advance PTSD research and help veterans, particularly since it leverages existing DoD research infrastructure and requires reporting to Congress.
They will look for assurance that the program is not duplicative of VA or NIH efforts, that there is clear budgetary discipline, and that implementation details — award criteria, evaluation metrics, and oversight — are well-specified.
Overall, centrists are inclined to support the bill provided there is clear justification of need, cost transparency, and effective coordination with VA and existing federal research programs.
A mainstream conservative is likely to view the bill favorably because it focuses on veterans’ health, strengthens ties with a strategic ally (Israel), and is limited in duration.
They will generally approve collaboration that could advance clinical tools for PTSD and favor DoD involvement given military relevance.
However, some conservatives may press for strict fiscal controls to ensure no open-ended spending and want assurances that research serves U.S. interests and security.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, the bill is a narrowly targeted, administratively straightforward authorization addressing veterans' mental health and international research collaboration — topics that generally enjoy bipartisan sympathy. Key barriers are procedural (Senate floor time and possible holds), the absence of a specific appropriation in the bill, and any policy concerns about foreign partnerships or agency jurisdiction. The presence of a sunset, reporting requirements, and private gift authority mitigate some objections and improve manageability.
- No cost estimate or appropriation language is included; whether Congress funds the program (and at what level) is unknown and materially affects implementation.
- The bill delegates many implementation details to the Secretary of Defense (eligibility criteria, award size, oversight mechanisms); those choices could affect buy-in from stakeholders or trigger interagency disputes (e.g., VA, NIH roles).
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Progressive is most likely to raise humanitarian or rights-based concerns about partnering specifically with Israeli institutions given con…
On content alone, the bill is a narrowly targeted, administratively straightforward authorization addressing veterans' mental health and in…
Relative to its intended legislative type, this bill successfully establishes a statutory basis for a U.S.–Israel PTSD collaborative research grant program and specifies responsible actors, applicant eligibility, a conn…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.